期刊文献+

合并心房颤动的急性非ST段抬高型心肌梗死患者血清半乳糖凝集素3和高敏C反应蛋白与临床预后的关系 被引量:15

Relationship between serum galectin-3 and hyper-sensitive C reactive protein and prognosis in patients with acute non-ST-segment elevation myocardial infarction complicated with atrial fibrillation
下载PDF
导出
摘要 目的探讨合并心房颤动(AF)的急性非ST段抬高型心肌梗死(NSTEMI)患者的血清半乳糖凝集素3和高敏C反应蛋白水平与预后的相关性。方法本研究为回顾性研究。纳入2014年1月至2015年12月在宝鸡市中医医院治疗的32例合并AF的NSTEMI患者作为AF组,并按年龄、性别匹配选取同期治疗的32例无AF的NSTEMI患者作为对照组,随访12个月,观察两组的主要心脑血管不良事件的情况。分析两组的血清半乳糖凝集素3和高敏C反应蛋白水平,应用多因素logistic回归分析评估血清半乳糖凝集素3和高敏C反应蛋白水平对预后的预测价值。结果与无AF的患者相比,合并AF患者的血清半乳糖凝集素3[(10.0±2.5)ng/ml比(8.6±2.5)ng/ml,P=0.02]和高敏C反应蛋白[(21.7±11.0)mg/L比(8.5±3.2)mg/L,P<0.001]明显升高。半乳糖凝集素3水平>7.53 ng/ml的患者发生不良事件的风险增加8倍(HR=8.06,95%CI:1.88~23.21,P=0.005),而高敏C反应蛋白>6.55 mg/L的患者发生不良事件的风险增加2.5倍(HR=2.53,95%CI:1.39~6.35,P=0.005)。结论合并AF的NSTEMI患者的血清半乳糖凝集素3和高敏C反应蛋白水平显著升高,半乳糖凝集素3和高敏C反应蛋白水平升高可预测患者发生心脑血管不良事件的风险。 Objective To investigate the correlation between serum galectin-3,hyper-sensitive C reactive protein(hs-CRP)levels and poor prognosis in patients with acute non-ST segment elevation acute myocardial infarction(NSTEMI)complicated with atrial fibrillation(AF).Methods This study was a retrospective study.Thirty-two patients with NSTEMI and AF were enrolled as the AF group,and another 32 cases of NSTEMI without AF as a control group,and all patients were followed-up to record the major adverse cardiac and cerebrovascular events(MACCE)for 12-month.The levels of serum galectin-3 and hsCRP between the two groups were compared,and the predictive value of serum galectin-3 and hsCRP for MACCE was analyzed by multivariate logistic regression analysis.Results Compared with patients without AF,the levels of serum galectin-3[(10.0±2.5)ng/ml vs.(8.6±2.5)ng/ml,P=0.02]and hsCRP[(21.7±11.0)mg/L vs.(8.5±3.2)mg/L,P<0.001]in patients with AF were significantly higher than those without AF.Patients with galectin-3>7.53 ng/ml had an 8-fold increased risk of MACCE(HR=8.06,95%CI:1.88-23.21,P=0.005)and those with hsCRP>6.55 mg/ml had a 2.5-fold increased risk of MACCE(HR=2.53,95%CI:1.39-6.35,P=0.005).Conclusions The levels of galectin-3 and hsCRP are significantly increased in NSTEMI patients with AF,and the elevated levels of galectin-3 and hsCRP could predict the risk of MACCE.
作者 邢尔克 贾军正 周红娟 Xing Erke;Jia Junzheng;Zhou Hongjuan(Department of Cardiology,Baoji City of Traditional Chinese Medicine,Baoji 721001,China;Department of Anesthesiology,Baoji City of Traditional Chinese Medicine,Baoji 721001,China)
出处 《中国心血管杂志》 2019年第1期62-66,共5页 Chinese Journal of Cardiovascular Medicine
关键词 心房颤动 心肌梗死 半乳糖凝集素3 高敏C反应蛋白 Atrial fibrillation Myocardial infarction Galectin-3 Hyper-sensitive C reactive protein
  • 相关文献

参考文献4

二级参考文献70

  • 1吕振成,查道刚,刘伊丽.553例心房颤动的病因分析──从3842例住院病人调查结果[J].岭南心血管病杂志,1996,2(2):31-33. 被引量:3
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 3急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1321
  • 4Madias JE, Patel DC,Singh D.Atrial fibrillation in acute myocarkial infarction.a perspective study based on data from a consecutive series of patient admitted to the coronary careunit[J].Clinic Cardiol,1996,19:180-186.
  • 5AKAO M,CHUN Y H,WADA H. Current status of clinical background of patients with atrial fibrillation in a community-based survey:the Fushimi AF Registry[J].{H}Journal of Cardiology,2013,(4):260-266.
  • 6Lok DJ, Lok SI, Bruggink-Andr de la Porte PW, et al. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure[J]. Clin Res Cardiol, 2013, 102: 103-110.
  • 7Fortuna-Costa A,Gomes AM, Kozlowski EO, et al. Extracellular galectin-3 in tumor progression and metastasis [ J ]. Front Oncol, 2014,4 : 138.
  • 8Gomes TS, Oshima CT, Forones NM, et al. Expression of galectin-3 in gastric adenocarcinoma [ J]. Indian J Med Res, 2014, 140: 69-76.
  • 9Haudek KC,Spronk K J, Voss PG, et al. Dynamics of galectin-3 in the nucleus and cytoplasm [ J ]. Biochimica et Biophysica Acta-General Subjects, 2010, 1800: 181-189.
  • 10Gao X, Balan V, Tai G, et al. Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway [ J ]. Oncotarget, 2014, 5: 2077-2084.

共引文献23

同被引文献114

引证文献15

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部